drugset / Trial / NCT05730205
Effects of the Contraceptive Implant in Women With Sickle Cell Disease
Non-randomizedCrossoverOpen-labelTreatment
Summary
The objective of this study is to measure the acceptability and impact of the progestin implant on frequency of vaso-occlusive crises, quality of life, and hematologic parameters in women with SCD.
Timeline
- Start
- 2023-08-02
- Primary completion
- 2027-03
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Etonogestrel | Unknown | 68 mg | — |